The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

David J. Kuter

Hematology Department

Massachusetts General Hospital




Name/email consistency: high



  • Hematology Department, Massachusetts General Hospital, Boston, Massachusetts. 1998 - 2012


  1. Health-related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care. Kuter, D.J., Mathias, S.D., Rummel, M., Mandanas, R., Giagounidis, A.A., Wang, X., Deuson, R.R. Am. J. Hematol. (2012) [Pubmed]
  2. Romiplostim. Kuter, D.J. Cancer Treat. Res. (2011) [Pubmed]
  3. Biology and chemistry of thrombopoietic agents. Kuter, D.J. Semin. Hematol. (2010) [Pubmed]
  4. Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia. Kuter, D.J. Annu. Rev. Med. (2009) [Pubmed]
  5. Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim. Kuter, D.J., Mufti, G.J., Bain, B.J., Hasserjian, R.P., Davis, W., Rutstein, M. Blood (2009) [Pubmed]
  6. New thrombopoietic growth factors. Kuter, D.J. Clin. Lymphoma. Myeloma (2009) [Pubmed]
  7. New drugs for familiar therapeutic targets: thrombopoietin receptor agonists and immune thrombocytopenic purpura. Kuter, D.J. Eur. J. Haematol. Suppl (2008) [Pubmed]
  8. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Kuter, D.J., Bussel, J.B., Lyons, R.M., Pullarkat, V., Gernsheimer, T.B., Senecal, F.M., Aledort, L.M., George, J.N., Kessler, C.M., Sanz, M.A., Liebman, H.A., Slovick, F.T., de Wolf, J.T., Bourgeois, E., Guthrie, T.H., Newland, A., Wasser, J.S., Hamburg, S.I., Grande, C., Lefrère, F., Lichtin, A.E., Tarantino, M.D., Terebelo, H.R., Viallard, J.F., Cuevas, F.J., Go, R.S., Henry, D.H., Redner, R.L., Rice, L., Schipperus, M.R., Guo, D.M., Nichol, J.L. Lancet (2008) [Pubmed]
  9. New thrombopoietic growth factors. Kuter, D.J. Blood (2007) [Pubmed]
  10. Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres. Kuter, D.J., Bain, B., Mufti, G., Bagg, A., Hasserjian, R.P. Br. J. Haematol. (2007) [Pubmed]
  11. Thrombotic complications of central venous catheters in cancer patients. Kuter, D.J. Oncologist (2004) [Pubmed]
  12. Recombinant human thrombopoietin: basic biology and evaluation of clinical studies. Kuter, D.J., Begley, C.G. Blood (2002) [Pubmed]
  13. Apoptosis in platelets during ex vivo storage. Kuter, D.J. Vox Sang. (2002) [Pubmed]
  14. Thrombopoietin therapy increases platelet yields in healthy platelet donors. Kuter, D.J., Goodnough, L.T., Romo, J., DiPersio, J., Peterson, R., Tomita, D., Sheridan, W., McCullough, J. Blood (2001) [Pubmed]
  15. Hematologic effects of antimicrobials: focus on the oxazolidinone linezolid. Kuter, D.J., Tillotson, G.S. Pharmacotherapy (2001) [Pubmed]
  16. Thrombopoietins and thrombopoiesis: a clinical perspective. Kuter, D.J. Vox Sang. (1998) [Pubmed]
WikiGenes - Universities